^
Association details:
| Biomarker: | POLE A456P |
|---|---|
| Cancer: | Colon Cancer |
| Drug Class: | Immunotherapy |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Clinicopathological and genomic characteristics of POLE-mutated colorectal cancer in a Chinese population
Published date:
05/19/2021
Excerpt:
A MSS patient with metastatic colon cancer harboring A456P POLE mutation responsed well to the immunotherpy and achieved a partial response.
DOI:
10.1200/JCO.2021.39.15_suppl.e15531
